Physiology/Pathophysiology of Vitamin B1 Transport in Pancreatic Acinar Cells
胰腺腺泡细胞中维生素 B1 运输的生理学/病理生理学
基本信息
- 批准号:10799411
- 负责人:
- 金额:$ 57.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-03-02 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:Acinar CellAcuteAddressAffectCell membraneCellsCellular biologyChronicCirculationComplexCytoplasmDiphosphatesDiseaseEndocrineEndotoxinsEnergy MetabolismEnvironmental Risk FactorEventExposure toFailureFlagellinFunctional disorderFundingGenesGoalsHealthHomeostasisHumanImpairmentInflammatoryInterleukin-1 betaInterleukin-6InvestigationKnockout MiceKnowledgeLeadLipopolysaccharidesLuciferasesMaintenanceMediatingMetabolicMicroRNAsMicronutrientsMitochondriaMolecularMolecular BiologyMorbidity - disease rateMusOrganOrganellesOxidation-ReductionOxidative StressPancreasPancreatic DiseasesPhysiologicalPhysiologyPlayPost-Transcriptional RegulationProcessProductionProteinsRegulationReporter GenesResearchRoleStructureSystemTNF geneTestingThiamineTranscriptional RegulationTransgenic MiceTransport ProcessVitamin DeficiencyVitaminsWater-Soluble Vitaminalcohol exposurecigarette smokecytokinedesignimprovedmicronutrient deficiencymortalitymouse modelnovelnutritionprogramspromoteruptake
项目摘要
Vitamin B1 (thiamin) is indispensable for normal function/health of pancreatic cells due its critical roles in
oxidative energy metabolism, ATP production, and in maintaining normal cellular redox state. Low
intracellular level of thiamin leads to acute energy failure, oxidative stress, and impairment in mitochondrial
function. At the organ level, the metabolically active pancreas maintains high levels of thiamin, and deficiency
of the vitamin impairs its functions. The pancreas cannot synthesis thiamin endogenously; rather it obtains it
from circulation. The overall goal of this research program since its inception has been focused on developing
a comprehensive understanding of the molecular mechanisms involved in thiamin uptake by pancreatic acinar
cells (PACs) and the subsequent transport (compartmentalization) of its major intracellular form, i. e., thiamin
pyrophosphate (TPP), into mitochondria, how these processes are regulated, and how they are affected by
exposure to external/internal factors that are known to adversely affect the normal physiology/health of the
pancreas. We have addressed many of these issues, and in the current proposal aim at determining: i) the role
of microRNAs in post-transcriptional regulation of THTR-1, THTR-2, and the mitochondrial TPP transporter
(MTPPT) expression in PACS, and the uptake processes that they mediate; ii) whether THTR- 1 and THTR-2
of PACs have interacting partners that affect/regulate their physiology/cell biology; and iii) the effect of
specific factors that PACs are exposed to under certain pathophysiological conditions [pro-inflammatory
cytokines, and the bacterial lipopolysaccharide (LPS) and flagellin] on thiamin uptake and on transport of TPP
into their mitochondria. Thus, in new preliminary studies evidence were obtained to suggest that microRNAs
regulate THTR-1 expression and thiamin uptake by PACs, that THTR-1 has interacting partner(s), and that
exposure of PACs to pro-inflammatory cytokines (especially those implicated in pancreatic disorders like IL-
6, TNF-α and IL-1β), as well as to LPS and flagellin, inhibit cellular thiamin uptake and transport of TPP into
mitochondria. Based on these new findings, our working hypotheses are: i) microRNAs play an important role
in post-transcriptional regulation of THTR-1, THTR-2, and MTPPT expression in PACs and the uptake events
they mediate; ii) PACs THTR-1 and THTR-2 have interacting partners that affect/regulate their physiology/cell
biology; and iii) pro- inflammatory cytokines, LPS and flagellin negatively impact PACs thiamin transport
physiology. We plan to test these hypotheses by accomplishing two specific aims and will utilize state-of the
art cellular/molecular approaches, human and mouse PACs, and appropriate transgenic mouse models. Results
of these investigations should provide novel information regarding vitamin B1 cellular/molecular transport
physiology in PACs and how internal/external factors affect the involved transport events. Such knowledge
may ultimately assist in the designing of effective strategies to optimize pancreatic thiamin homeostasis, and
thus, improve the health of the pancreas.
维生素B1(硫胺素)对于胰腺细胞的正常功能/健康是不可或缺的,因为它在以下方面的关键作用:
氧化能量代谢、ATP产生和维持正常细胞氧化还原状态。低
细胞内硫胺素水平导致急性能量衰竭、氧化应激和线粒体损伤。
功能在器官水平上,代谢活跃的胰腺维持高水平的硫胺素,
会损害它的功能。胰腺不能内源性合成硫胺素,而是通过获取维生素B1,
从流通。该研究项目自成立以来的总体目标一直集中在开发
对胰腺腺泡摄取硫胺素的分子机制有了全面的了解,
细胞(PAC)及其主要细胞内形式的后续运输(区室化),即。例如,硫胺素
焦磷酸盐(TPP),进入线粒体,这些过程是如何调节的,以及它们是如何受到
暴露于已知会对正常生理/健康产生不利影响的外部/内部因素
胰腺我们已经处理了其中的许多问题,在目前的建议中,旨在确定:
微RNA在THTR-1、THTR-2和线粒体TPP转运蛋白转录后调节中的作用
(ii)THTR- 1和THTR-2是否在PACS中表达,以及它们介导的摄取过程;
的PAC具有影响/调节其生理学/细胞生物学的相互作用伴侣;和iii)
PAC在某些病理生理条件下暴露的特定因素[促炎性
细胞因子、细菌脂多糖(LPS)和鞭毛蛋白]对硫胺素摄取和TPP转运的影响
进入线粒体。因此,在新的初步研究中获得的证据表明,microRNA
调节THTR-1表达和PAC对硫胺素的摄取,THTR-1具有相互作用的配偶体,
PAC暴露于促炎性细胞因子(特别是与胰腺疾病有关的那些,如IL-1),
6、TNF-α和IL-1β)以及LPS和鞭毛蛋白,抑制细胞硫胺素摄取和TPP转运到
线粒体基于这些新的发现,我们的工作假设是:i)microRNA发挥重要作用,
THTR-1、THTR-2和MTPPT在PAC中表达的转录后调节以及
它们介导; ii)PAC THTR-1和THTR-2具有影响/调节其生理/细胞的相互作用伴侣
促炎细胞因子、LPS和鞭毛蛋白对PAC硫胺素转运产生负面影响
physiology.我们计划通过实现两个具体目标来测试这些假设,并将利用
细胞/分子方法、人和小鼠PAC以及适当的转基因小鼠模型。结果
这些研究将提供有关维生素B1细胞/分子转运的新信息
PAC的生理学以及内部/外部因素如何影响所涉及的运输事件。这种知识
可能最终有助于设计有效的策略来优化胰腺硫胺素稳态,
从而改善胰腺的健康。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Chronic alcohol exposure negatively impacts the physiological and molecular parameters of the renal biotin reabsorption process.
慢性酒精暴露会对肾脏生物素重吸收过程的生理和分子参数产生负面影响。
- DOI:10.1152/ajprenal.00707.2010
- 发表时间:2011
- 期刊:
- 影响因子:0
- 作者:Subramanian,VeedamaliS;Subramanya,SandeepB;Said,HamidM
- 通讯作者:Said,HamidM
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAMID M SAID其他文献
HAMID M SAID的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAMID M SAID', 18)}}的其他基金
Effect of Pathophysiological Conditions on Intestinal Absorption of Free Thiamin
病理生理条件对游离硫胺素肠道吸收的影响
- 批准号:
10246647 - 财政年份:2022
- 资助金额:
$ 57.99万 - 项目类别:
Effect of Pathophysiological Conditions on Intestinal Absorption of Free Thiamin
病理生理条件对游离硫胺素肠道吸收的影响
- 批准号:
10651601 - 财政年份:2022
- 资助金额:
$ 57.99万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10585365 - 财政年份:2022
- 资助金额:
$ 57.99万 - 项目类别:
Mechanism/Regulation of Intestinal Thiamin Uptake
肠道硫胺素摄取的机制/调节
- 批准号:
9087015 - 财政年份:2014
- 资助金额:
$ 57.99万 - 项目类别:
Mechanism/Regulation of Intestinal Thiamin Uptake
肠道硫胺素摄取的机制/调节
- 批准号:
8791430 - 财政年份:2014
- 资助金额:
$ 57.99万 - 项目类别:
Physiological and Pathological Aspects of Intestinal Vitamin B2 Absorption
肠道维生素 B2 吸收的生理和病理方面
- 批准号:
9026398 - 财政年份:2012
- 资助金额:
$ 57.99万 - 项目类别:
Physiological and Pathological Aspects of Intestinal Vitamin B2 Absorption
肠道维生素 B2 吸收的生理和病理方面
- 批准号:
9553448 - 财政年份:2012
- 资助金额:
$ 57.99万 - 项目类别:
Physiological and Pathological Aspects of Intestinal Vitamin B2 Absorption
肠道维生素 B2 吸收的生理和病理方面
- 批准号:
9215519 - 财政年份:2012
- 资助金额:
$ 57.99万 - 项目类别:
Intestinal Vitamin B2 Absorption: Molecular/Cellular Aspects and Effects of Alcoh
肠道维生素 B2 吸收:分子/细胞方面和酒精的影响
- 批准号:
8139616 - 财政年份:2011
- 资助金额:
$ 57.99万 - 项目类别:
Intestinal Vitamin B2 Absorption: Molecular/Cellular Aspects and Effects of Alcoh
肠道维生素 B2 吸收:分子/细胞方面和酒精的影响
- 批准号:
8803250 - 财政年份:2011
- 资助金额:
$ 57.99万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 57.99万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 57.99万 - 项目类别:
Operating Grants